Balance Labs, Inc. financial data

Symbol
BLNC on OTC
Location
Miami, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.3% % -63%
Debt-to-equity -101% % 2.3%
Return On Equity 9% % -28%
Return On Assets -360% % -135%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46,852,319 shares 116%
Common Stock, Shares, Outstanding 22,454,264 shares 3.6%
Entity Public Float $5,418,500 USD
Common Stock, Value, Issued $2,245 USD 3.6%
Weighted Average Number of Shares Outstanding, Basic 22,004,764 shares 1.5%
Weighted Average Number of Shares Outstanding, Diluted 22,004,764 shares 1.5%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $16,296 USD -41%
Operating Income (Loss) $433,240 USD -105%
Nonoperating Income (Expense) $3,431,715 USD -947%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,406 USD 95%
Net Income (Loss) Attributable to Parent $417,686 USD -1.6%
Earnings Per Share, Basic 0 USD/shares -500%
Earnings Per Share, Diluted 0 USD/shares -500%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,512 USD -85%
Marketable Securities, Current $48,628 USD -39%
Assets, Current $53,140 USD -52%
Assets $53,140 USD -52%
Accrued Liabilities, Current $45,016 USD
Liabilities, Current $8,728,825 USD 72%
Liabilities $8,728,825 USD 72%
Retained Earnings (Accumulated Deficit) $9,630,533 USD -67%
Stockholders' Equity Attributable to Parent $8,675,685 USD -75%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5,077,512 USD -9%
Liabilities and Equity $53,140 USD -52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,659 USD 39%
Net Cash Provided by (Used in) Financing Activities $12,500 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 22,454,264 shares 3.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,159 USD 73%
Deferred Tax Assets, Gross $1,241,199 USD 16%
Depreciation $0 USD
Property, Plant and Equipment, Gross $6,160 USD -38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Additional Paid in Capital $952,603 USD 18%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $142,633 USD
Interest Expense $224,969 USD -2.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%